UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 3)*
INVERNESS MEDICAL INNOVATIONS, INC.
(Name of Issuer)
COMMON STOCK, $0.001 PAR VALUE PER SHARE
(Title of Class of Securities)
46126P106
(CUSIP Number)
DECEMBER 31, 2005
(Date of Event which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Continued on following pages
Page 1 of 9 Pages
2
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
PERRY CORP.
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [ ]
3 SEC Use Only
4 Citizenship or Place of Organization
NEW YORK
5 Sole Voting Power
Number of 502,226
Shares
Beneficially 6 Shared Voting Power
Owned By 0
Each
Reporting 7 Sole Dispositive Power
Person 502,226
With
8 Shared Dispositive Power
0
9 Aggregate Amount Beneficially Owned by Each Reporting Person
502,226
10 Check Box If the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
[ ]
11 Percent of Class Represented By Amount in Row (9)
1.83%
12 Type of Reporting Person (See Instructions)
IA, CO
3
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
RICHARD C. PERRY
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [ ]
3 SEC Use Only
4 Citizenship or Place of Organization
UNITED STATES
5 Sole Voting Power
Number of 502,226
Shares
Beneficially 6 Shared Voting Power
Owned By 0
Each
Reporting 7 Sole Dispositive Power
Person 502,226
With
8 Shared Dispositive Power
0
9 Aggregate Amount Beneficially Owned by Each Reporting Person
502,226
10 Check Box If the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
[ ]
11 Percent of Class Represented By Amount in Row (9)
1.83%
12 Type of Reporting Person (See Instructions)
IN, HC
4
ITEM 1(A) NAME OF ISSUER:
Inverness Medical Innovations, Inc. (the "Issuer").
ITEM 1(B) ADDRESS OF THE ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
51 Sawyer Road, Suite 200
Waltham, MA 02453
ITEM 2(A) NAME OF PERSON FILING:
This statement is filed on behalf of each of the following persons
(collectively, the "Reporting Persons"):
i) Perry Corp.; and
ii) Richard C. Perry, in his capacities as the President and sole
stockholder of Perry Corp. ("Mr. Perry").
This statement relates to Shares (as defined herein) held for the accounts
of two or more private investment funds for which Perry Corp. acts as general
partner and/or managing member of the general partner and/or investment adviser.
ITEM 2(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
The address of the principal business office of each of the Reporting
Persons is 767 Fifth Avenue, New York, New York 10153.
ITEM 2(C) CITIZENSHIP:
1) Perry Corp. is a New York corporation; and
2) Mr. Perry is a citizen of the United States.
ITEM 2(D) TITLE OF CLASS OF SECURITIES:
Common Stock, $0.001 par value per share (the "Shares").
ITEM 2(E) CUSIP NUMBER:
4612P106
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR
(C), CHECK WHETHER THE PERSON FILING IS A:
i) Perry Corp. is an investment adviser registered under Section 203
of the Investment Advisers Act of 1940.
ii) Mr. Perry is a control person of Perry Corp.
5
ITEM 4. OWNERSHIP:
ITEM 4(A) AMOUNT BENEFICIALLY OWNED:
As of the Date of Event, each of the Reporting Persons may be deemed to be
the beneficial owner of 502,226 Shares. This number consists of (1) 462,226
Shares beneficially owned by the Reporting Persons, and (2) 40,000 Shares
issuable upon exercise of certain warrants beneficially owned by the Reporting
Persons.
ITEM 4(B) PERCENT OF CLASS:
As of the Date of Event, the number of Shares outstanding was 27,411,965
according to the Issuer's Quarterly Report on Form 10-Q for the quarter ended
September 30, 2005 filed on November 9, 2005 (the "Quarterly Report"). As of the
Date of Event, each of the Reporting Persons may be deemed to be the beneficial
owner of approximately 1.83% of the total number of Shares outstanding. This
percentage was calculated by dividing (i) (A) the total amount of Shares
beneficially owned by the Reporting Persons, plus (B) the total amount of Shares
issuable upon exercise of certain warrants beneficially owned by the Reporting
Persons, by (ii) (x) the total number of Shares outstanding as reported by the
Issuer in the Quarterly Report, plus (y) the total amount of Shares issuable
upon exercise of certain warrants beneficially owned by the Reporting Persons.
ITEM 4(C) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
PERRY CORP.
(i) Sole power to vote or direct the vote 502,226
(ii) Shared power to vote or to direct the vote 0
(iii) Sole power to dispose or to direct the disposition of 502,226
(iv) Shared power to dispose or to direct the disposition of 0
MR. PERRY
(i) Sole power to vote or direct the vote 502,226
(ii) Shared power to vote or to direct the vote 0
(iii) Sole power to dispose or to direct the disposition of 502,226
(iv) Shared power to dispose or to direct the disposition of
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [X].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
The limited partners of (or investors in) each of the private investment
funds for which Perry Corp. acts as general partner and/or managing member of
the general partner and/or investment adviser have the right to participate in
the receipt of dividends from, or proceeds from the sale of, the securities held
for the accounts of their respective funds in accordance with their respective
limited partnership interest (or investment percentages) in their respective
funds.
6
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
Perry Corp. is the relevant entity for which Mr. Perry may be
considered a control person.
Perry Corp. is an investment adviser registered under the Investment
Advisers Act of 1940.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
This Item 8 is not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
This Item 9 is not applicable.
ITEM 10. CERTIFICATION:
By signing below each of the Reporting Persons certifies that, to the best
of such person's knowledge and belief, the securities referred to above were
acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or
influencing the control of the Issuer of such securities and were not acquired
and are not held in connection with or as a participant in any transaction
having such purpose or effect.
7
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Date: February 10, 2006 PERRY CORP.
By: Richard C. Perry
Title: President
By: /s/ Michael C. Neus
---------------------------------
Michael C. Neus
Attorney-in-Fact
Date: February 10, 2006 RICHARD C. PERRY
By: /s/ Michael C. Neus
-------------------------------------
Michael C. Neus
Attorney-in-Fact
7
EXHIBIT INDEX
PAGE NO.
A. Joint Filing Agreement, dated as of February 10, 2006, by and among the Reporting
Persons................................ 9
8
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with
respect to the Common Stock, $0.001 par value, of Inverness Medical Innovations,
Inc., dated as of February 10, 2006, is, and any amendments thereto (including
amendments on Schedule 13D) signed by each of the undersigned shall be, filed on
behalf of each of us pursuant to and in accordance with the provisions of Rule
13d-1(k) under the Securities Exchange Act of 1934.
Date: February 10, 2006 PERRY CORP.
By: Richard C. Perry
Title: President
By: /s/ Michael C. Neus
---------------------------------
Michael C. Neus
Attorney-in-Fact
Date: February 10, 2006 RICHARD C. PERRY
By: /s/ Michael C. Neus
-------------------------------------
Michael C. Neus
Attorney-in-Fact
9